Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | |
| Sales | 30 | 893 | 935 |
| Gross Profit | 30 | 893 | 935 |
| Operating Expenses | 3,414 | 3,979 | 5,353 |
| Operating Income | -3,385 | -3,086 | -4,418 |
| Interest Expense | 219 | 157 | 57 |
| Other Income | 1 | 11 | 23 |
| Pre-tax Income | -3,602 | -3,232 | -4,452 |
| Net Income Continuous | -3,602 | -3,232 | -4,452 |
| Net Income | $-3,602 | $-3,232 | $-4,452 |
| EPS Basic Total Ops | -15.66 | -14.94 | -19.85 |
| EPS Basic Continuous Ops | -16.20 | -14.54 | -20.08 |
| EPS Diluted Total Ops | -15.66 | -14.94 | -19.85 |
| EPS Diluted Continuous Ops | -16.20 | -14.54 | -20.08 |
| EBITDA(a) | $-3,268 | $-2,982 | $-4,322 |